Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$227K Sell
3,193
-1,663
-34% -$114K ﹤0.01% 1409
2025
Q4
$288K Sell
4,856
-161
-3% -$8.74K ﹤0.01% 1249
2025
Q3
$277K Buy
5,017
+27
+0.5% +$1.4K ﹤0.01% 1276
2025
Q2
$215K Buy
+4,990
New +$192K ﹤0.01% 1364
2024
Q4
Sell
-9,915
Closed -$376K 1695
2024
Q3
$376K Sell
9,915
-1,329
-12% -$52.9K 0.01% 1071
2024
Q2
$474K Buy
+11,244
New +$543K 0.01% 834

Other funds holding NGVT

Choreo LLC's NGVT Position: Q1 2026 in Review

Choreo LLC reduced its Ingevity (NGVT) stake by 34% in Q1 2026, selling an estimated $114K and leaving 3,193 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #1409.

Choreo LLC first reported a position in NGVT in Q2 2024 and has held it in 6 quarters since. The position peaked at $474K in Q2 2024. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Choreo LLC held 3,193 shares of Ingevity worth $227K as of Q1 2026.
  • Choreo LLC sold 1,663 Ingevity shares in Q1 2026, an estimated $114K.
  • Ingevity made up ﹤0.01% of Choreo LLC's portfolio in Q1 2026, its #1409 holding.
  • Choreo LLC first reported a position in Ingevity in Q2 2024 and has held it in 6 quarters since.
  • Choreo LLC's Ingevity position peaked at $474K in Q2 2024.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.